EZHIP and neoplasm: DNA methylation profiling can stratify H3K27 altered DMGs from other paediatric high-grade glioma [11], and can also distinguish between H3.1K27M and H3.3K27M tumour samples [66, 67] and EZHIP overexpressing and EGRF positive subtypes [35], suggesting a different cell of origin.